Two experiments were conducted on postpartum suckled beef cows synchronized with Syncro-Mate B and artificially inseminated approximately 48 h after implant removal. In Exp. 1, cows ( ≥ 42 d postpartum at the timed AI) were randomly assigned to treated ( n = 101) and control ( n = 85) groups on d 12 after the timed AI. Treated cows received norgestomet/silicone implants that were left in situ for 9 d. Norgestomet treatment had no effect ( P > .25) on the calving rates from the initial timed AI or from the return estrus. Nonpregnant norgestomettreated cows returned to estrus in a more ( P < .05) synchronized manner than the nonpregnant control cows. In Exp. 
Introduction
Two factors limiting the use of artificial insemination ( AI) are postpartum anestrous and estrus detection. One method (Syncro-Mate B ® ; SMB) that has been developed to hasten estrus in postpartum cows uses a combination of norgestomet and estradiol valerate (Wishart and Young, 1974; Spitzer et al., 1978; Odde, 1990) . The SMB (Rhone Merieux, Overland Park, KS) treatment is effective in inducing estrus and ovulation in both anestrous and cyclic beef heifers and cows (Hixon et al., 1981; Ghallab et al., 1984; Odde, 1990) and provides the degree of synchrony required for a single timed insemination (Miksch et al., 1978; Anderson et al., 1982) .
Current estrus synchronization procedures are used to synchronize only one estrus and ovulation. Favero et al. (1993) found that administration of norgestomet implants to beef heifers on d 9 or 12 through 21 after a timed AI increased the calving rate from the timed AI and synchronized the return estrus of the nonpregnant treated heifers. The studies herein involved administering norgestomet to postpartum suckled beef cows synchronized with SMB to determine whether norgestomet treatment after breeding would 1 ) enhance the SMB synchronized calving rate and 2 ) synchronize the return estrus of nonpregnant cows. An additional objective was to determine whether this procedure would hasten the establishment of pregnancy in early postpartum suckled beef cows.
Materials and Methods
Two experiments were conducted with purebred Angus and crossbred Simmental cows maintained on pasture from the University of Illinois Beef Research Unit at Urbana. All females were initially synchronized with SMB. The SMB treatment consisted of an intramuscular injection of norgestomet (3.0 mg) Controls  15  48  22  ----Treated c  30  47  24  11  33  19  55  Implant formulation d  1  2  3  3  3  3  3  Age ( X ± SE) 3.7 ± .4 3.7 ± .3 3.8 ± .4 3.7 ± .6 3.7 ± .4 3.8 ± .5 3.7 ± .3 Days postpartum ( X ± SE) e 70.8 ± 5.8 72.9 ± 7.5 67.7 ± 5.6 24.4 ± 2.4 72.1 ± 5.7 25.1 ± 1.9 69.8 ± 6.7 Figure 1 . Schedule of treatments for Exp. 1 and 2. All cows (in Exp. 1 and 2) were administered the SyncroMate B (SMB) procedure. In Exp. 1 approximately half of the cows were administered norgestomet implants 12 d after AI. In Exp. 2, all cows were administered norgestomet implants on d 12. Norgestomet implants were removed 21 d after the first AI. In Exp. 1, cows subsequently detected in estrus were bred by the am/ pm rule. In Exp. 2, a blood sample was collected on d 21 and cows with low progesterone concentrations (< 1.5 ng/mL) were bred approximately 48 h after the removal of the norgestomet implant. and estradiol valerate (5.0 mg) in sesame oil and benzyl alcohol and an ear implant containing 6.0 mg of norgestomet. The implant was subcutaneously inserted into the convex surface of the ear. After 9 d the norgestomet implants were removed. Approximately 48 h after removal of the norgestomet implants all cows were artificially inseminated with commercially frozen semen. Service sire selection was made before the timed AI and before allotment to the groups.
In Exp. 1, 186 postpartum suckled beef cows (42 to 112 d postpartum at the time of the SMB treatment) were randomly assigned to treated and control groups on d 12 after the SMB-timed AI (Figure 1 ). This experiment was done over a 3-yr period. All cows included in the experiment were greater than 30 d postpartum at SMB treatment ( ≥ 42 d postpartum at the first AI). Within each year, allotment to control and treatment groups was done randomly. The treated cows ( n = 101) were subcutaneously implanted (on the convex surface of the ear) with norgestomet/ silicone implants (three formulations) that released a dosage of norgestomet sufficient to suppress estrus (Machado and Kesler, 1995) . The control cows ( n = 85) received no further treatment. Days postpartum and cow age, which were similar ( P > .25) between treatment groups, number of cows per group by year, and implant formulation used each year are reported in Table 1 .
In Exp. 2, 118 postpartum suckled beef cows ( 7 to 112 d postpartum at the time of the SMB treatment) were assigned to two groups based on the postpartum interval when the SMB-synchronized AI was done. Cows were either < 42 d postpartum at the time of the first AI ( n = 30; group 1 ) or were ≥ 42 d postpartum ( n = 88; group 2 ) at the time of the first AI. All cows received a norgestomet/silicone implant 12 d after the first AI ( Figure 1 ). Blood samples were collected via jugular venipuncture 21 d after the first AI and assayed for progesterone concentrations via a validated enzyme immunoassay . Experiment 2 was conducted over a 2-yr period. Cow age, which was similar ( P > .25) between treatment groups, days postpartum, number of cows per group by year, and implant formulation used each year are reported in Table 1 .
All cows were observed for signs of behavioral estrus at least twice daily, morning and evening, beginning on the day after the SMB-timed AI until d 35 of the breeding season. Standing to be mounted was the criterion used to determine estrus. The polymer used in the implants that were administered to the treated females was silicone (polydimethylsiloxane), whereas the polymer hydron (polyethylene glycomethacrylate) was used in the norgestomet implants that were administered at the initial SMB estrus synchronization. Implants from the three silicone implant formulations released a norgestomet dosage within the range of the amount of norgestomet released from the SMB hydron implant (Kesler and Favero, 1989; Kesler et al., 1995) . Exact compositions of the silicone formulations were not disclosed to the investigators. Formulations 1, 2, and 3 were used in yr 1, 2, and 3, respectively, of Exp. 1 (Table 1) . Formulation 3 was used in yr 1 and 2 of Exp. 2 (Table 1) .
During the trials the implants were removed from the treated females on d 21 after the SMB-timed artificial insemination. Females that returned to estrus were artificially inseminated approximately 12 h after they were detected in estrus (Exp. 1 ) or 48 h after implant removal if progesterone concentrations were < 1.5 ng/mL at implant removal (Exp. 2). Favero (1992) demonstrated that the two methods of selecting cows to be bred resulted in equivalent calving rates. Service sire selection was made before the timed AI and before allotment to the groups. Females were exposed to bulls beginning on d 26 after the initial SMB-timed artificial insemination. The total breeding season for both experiments was 63 d ( d 1 = the day of the first AI).
Calving rates were determined by calving dates. Cows were considered to have calved to an AI if they calved 283 ± 11 d after insemination. Calving rates and estrus response were analyzed using analysis of variance (the GLM procedure of SAS; 1988). Factors included in analysis were breed (Angus and crossbred), year/implant formulation (confounded within year), treatment (control and norgestomet; Exp. 1 only), and postpartum interval (Exp. 2 only). Year/ implant formulation (confounded within year) and breed and their interactions were not significant ( P > .10) and because they were not factors of interest in these studies they were not considered further.
Results and Discussion
In Exp. 1 the calving rates from the initial timed, return estrus, and cumulative artificial inseminations were similar ( P > .25) between control and norgestomet-treated cows (Table 2) . This differs from studies conducted in dairy cows in which progesterone administration (via intravaginal devices) during the early or mid-luteal phase increased the pregnancy rate to the first artificial insemination (Robinson et al., 1989) . Studies using daily injections of progesterone or synthetic progestins reported an increase in pregnancy rate due to treatment (Wiltbank et al., 1956; Johnson et al., 1958) . Salgado and Donaldson (1984) found that progestins administered via intravaginal sponges at the time of embryo transfer increased the pregnancy rate in treated Holstein embryo transfer recipients.
In agreement with the data in this study, Van Cleeff et al. (1991) were not able to detect a difference in the pregnancy rate of control heifers and heifers treated with progesterone-releasing intravaginal devices that were administered on d 7 to 13 after artificial insemination. Similarly, Stevenson and Mee (1991) treated cows with progesterone-releasing intravaginal devices on d 5 to 13 or d 13 to 21 after artificial insemination. The treatment did not improve the pregnancy rate from the artificial insemination and either delayed the interval to, or the detection of, the return estrus of the nonpregnant females. Washburn and McCraw (1990) obtained similar results when norgestomet implant administration (hydron norgestomet implants as part of SMB treatment) was initiated on d 9 to 16 and continued for 10 d. The treatment did not improve the conception rate from the initial timed artificial insemination.
The calving rates from the artificial insemination at the return estrus also were similar ( P > .25) between groups (Table 2 ). This suggests that a 9-d norgestomet treatment may not be detrimental to fertility at the subsequent estrus, as had been reported by Washburn and McCraw (1990) .
The effect of norgestomet treatment on estrus detection efficacy at the return estrus (estrus occurring before d 26 after the initial timed artificial insemination) is reported in Table 3 . The total number of nonpregnant cows used in this comparison was the number of females that did not calve to the initial timed artificial insemination. Overall, the rate of estrus detection at the return estrus was 73% for cows in the norgestomet-treated groups vs 58% for control cows ( P = .12). This is opposite to a study using progesterone-releasing intravaginal devices (Stevenson and Mee, 1991) . In that study it was found that administration of progesterone on d 5 to 13 or d 13 to 21 increased the percentage of nonpregnant heifers that did not display a return estrus for an extended period of time. b Differs ( P < .05) from the first AI pregnancy rate for cows ≥ 42 d postpartum.
c The percentage is based on the number pregnant divided by the number bred at the second artificial insemination (AI). Norgestomet treatment synchronized ( P < .05) the return estrus of the norgestomet-treated cows. Eightyone percent of the treated cows were detected in estrus during the 3-d period of peak estrus activity for the treated cows compared with 56% for the control cows. Most of the norgestomet-treated cows returned to estrus approximately 48 h after norgestomet implant removal. Only one of the 101 (1.0%) norgestomettreated cows exhibited estrus during norgestomet implant period, whereas 17 of the 85 control cows (20%) exhibited estrus before d 21.
In Exp. 2, cows that were ≥ 42 d postpartum at the first AI had a higher ( P < .05) calving rate than cows inseminated < 42 d postpartum (Table 4) Calving rate to the second AI (cows from the < 42 d postpartum group that were bred a second time) of 53% (after two implantation periods) tended to be greater ( P = .11) than the pregnancy rate of 27% for the cows that were at an equal stage postpartum (33 to 59 d ) after only one norgestomet implantation (cows selected from the ≥ 42 d postpartum group based on postpartum interval; Table 4 ). This may suggest that after the second implantation period of norgestomet, fertility of the postpartum cows had returned to normal. The cumulative pregnancy rate from the first and second AI (23-d period) was similar ( P > .10) for both intervals postpartum.
We previously presented similar data for studies conducted in heifers (Favero et al., 1993) . In that study we found that beef heifers could be treated with norgestomet on d 9 or 12 through 21 without adverse effects on fertility. In that study we found that the treatment had significant effects on the estrus synchrony at the return estrus of the nonpregnant treated heifers. In contrast, when norgestomet treatment was used on heifers, the treatment resulted in an increase in calving rate from the initial SMB-timed AI.
It is unclear why similar norgestomet/silicone implants administered during the same time after insemination enhanced pregnancy rates in heifers (Favero et al., 1993) but not in cows. A basis for postinsemination norgestomet enhancement of pregnancy rates has not been developed. We have demonstrated that norgestomet implants were capable of maintaining pregnancy in heifers that were ovariectomized on d 10 after breeding . However, in intact females if the corpus luteum regressed and the implant were maintaining the pregnancy, there would be no source of progesterone to maintain pregnancy after implant removal. Therefore, the postinsemination norgestomet treatment acts in some other manner to enhance pregnancy in heifers but not in cows.
Recent experiments using the commercial hydron norgestomet implant (SMB implant) have demonstrated that when it was implanted during proestrus, the dominant follicle present was maintained for the duration of the treatment and there was no growth of medium or small follicles (Rajamahendran and Taylor, 1991) . Systemic estradiol concentrations were also elevated, and there was insufficient progestin activity to maintain a strong negative feedback on luteinizing hormone pulse frequency in a manner comparable to that of the luteal phase of a normal estrous cycle (Savio et al., 1993) . Regression of persistent follicles during the progestin administration increased fertility after progestin withdrawal (Anderson and Day, 1994) and can be accomplished by providing progesterone (Stock and Fortune, 1993) or additional norgestomet (Savio et al., 1993) . Because the norgestomet implants were administered during diestrus when the corpus luteum was still synthesizing progesterone, persistent follicles may not have developed as for Savio et al. (1993) and Rajamahendran and Taylor (1991) , allowing for more optimal pregnancy rates at the return estrus.
Implications
The combined procedures, Syncro-Mate B synchronization and norgestomet treatment, hastened the establishment of pregnancy in early postpartum suckled beef cows and synchronized the return estrus in the nonpregnant cows. Therefore, the combined procedures may be an efficacious method of reducing the calving interval in early postpartum suckled beef cows and synchronizing the return estrus in cows not conceiving to the synchronized insemination. Although more animal handlings would be required, a greater number of more economically valuable AI calves could be produced in early postpartum suckled beef cows.
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